## Skeptic's Final Assessment
### Addressed Concerns
The theorist's framework made several testable predictions that would have partially addressed my critiques: NRF2 activator experiments in patient-derived motor neurons and cysteine mutagenesis to prevent TDP-43 oxidation. Had the rebuttal provided data on motor neurons treated pre-symptomatically showing TDP-43 cytoplasmic mislocalization prevented, this would have strengthened the temporal argument. Similarly, mutagenesis of oxidation-prone cysteines (C173, C175) reducing cytoplasmic aggregation in oxidative stress models would address the causal mechanism question.
### Unresolved Issues
**Bidirectional causality remains the core problem.** The theorist never addressed my pointing to Chung et al. (2020; PMID: 32176620) demonstrating that TDP-43 loss-of-function disrupts nuclear-encoded mitochondrial gene expression, directly causing oxidative phosphorylation impairment. This establishes TDP-43 pathology can *generate* the oxidative stress the hypothesis claims drives TDP-43 mislocalization. Without genetic separation experiments (SOD1^G93A^ crossed with TDP-43 knockdown), temporal causality cannot be resolved.
**The clinical trial failure paradox persists.** If oxidative stress is genuinely upstream of TDP-43 pathology in sporadic ALS, broad antioxidants should demonstrate efficacy. The consistent failure of vitamin E, CoQ10, selegiline, and only marginal benefit from edaravone (PMCID: PMC6419469) suggests either: (a) oxidative stress is not the primary upstream trigger, or (b) the relevant oxidative pathways are not being targeted by systemically administered antioxidants. The theorist did not reconcile this.
**Non-SOD1 models remain untested.** The entire evidence base relies on SOD1 rodent models. The falsification experiment—testing NRF2 activators in TDP-43 mutation carriers—was never addressed.
### Key Undermining Paper
**Fang et al. (2022; PMID: 35580632)** provides direct evidence that TDP-43 depletion itself causes mitochondrial dysfunction preceding oxidative stress, with bioinformatics showing TDP-43 Regulates mitochondrial dynamics genes. This supports the skeptic position that TDP-43 dysfunction drives oxidative stress downstream, not upstream.
### Final Confidence Score: **0.25**
**Key Remaining Gap:** The framework cannot explain sporadic ALS pathophysiology without SOD1 mutation; bidirectional causality is not resolved by correlation data; and clinical translation failures in antioxidant trials constitute the most direct evidence against upstream oxidative stress causation in human disease.